Formula PTX Renal Stent Clinical Study
- Conditions
- Renal Artery Stenosis
- Interventions
- Device: Formula PTX Stent - Dose 3Device: Formula PTX Stent - Dose 1Device: Formula PTX Stent - Dose 2
- Registration Number
- NCT01057316
- Lead Sponsor
- Cook Group Incorporated
- Brief Summary
The purpose of the study is to evaluate the safety and effectiveness of the PTX-coating on the Formula PTX Balloon-Expandable Stent in treatment of renal artery stenosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- renal artery stenosis
- appropriate size and location of the lesion
- pregnant or breast feeding
- failure or inability to give informed consent
- simultaneously participating in another drug or device study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Study Group C Formula PTX Stent - Dose 3 - Study Group A Formula PTX Stent - Dose 1 - Study Group B Formula PTX Stent - Dose 2 -
- Primary Outcome Measures
Name Time Method Percent Diameter Stenosis of the Treated Renal Artery 9 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (12)
University Hospital Ostrava
🇨🇿Ostrava-Poruba, Czechia
Royal Sussex County Hospital
🇬🇧Brighton, United Kingdom
St. Bonifatius Hospital
🇩🇪Lingen, Germany
Institute for Clinical and Experimental Medicine
🇨🇿Prague, Czechia
Herz-Zentrum Bad Krozingen
🇩🇪Bad Krozingen, Germany
Kent & Canterbury Hospital
🇬🇧Canterbury, United Kingdom
Hopital Europeen Georges Pomidou
🇫🇷Paris, France
St. Mary's Hospital
🇬🇧London, United Kingdom
Klinik Dr. Hancken im Elbe Klinikum Stade
🇩🇪Stade, Germany
Krankenhaus Neu-Bethlehem
🇩🇪Göttingen, Germany
Uniklinik Heidelberg
🇩🇪Heidelberg, Germany
Universitatsklinikum Leipzig AoR
🇩🇪Leipzig, Germany